Description
A prodrug form of cysteine with antioxidant activity; reduces TNF-α-induced increases in IL-6 and CCL2 expression in ARPE-19 human retinal pigment epithelial cells at 0.5 mM; increases liver GSH levels in fasted, but not fed, mice at 6.5 mmol/kg; reduces ROS production in BALF and decreases plasma extravasation in the lungs, as well as reverses decreases in HIF-1α levels in a mouse model of allergic asthma at 80 and 160 mg/kg
Formal name: 2-oxo-(4R)-4-thiazolidinecarboxylic acid
Synonyms: L-2-oxothiazolidine-4-carboxylate|L-2-oxothiazolidine-4-carboxylic acid|OTC
Molecular weight: 147.2
CAS: 19771-63-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation|Allergy||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen||Research Area|Oxidative Stress & Reactive Species|Reactive Sulfur|Glutathione